Union Bancaire Privee UBP SA cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 99.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 123 shares of the healthcare conglomerate's stock after selling 52,329 shares during the quarter. Union Bancaire Privee UBP SA's holdings in UnitedHealth Group were worth $38,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Financial Management Professionals Inc. grew its position in UnitedHealth Group by 0.8% in the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after acquiring an additional 17 shares during the period. Retirement Planning Group LLC grew its position in UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after acquiring an additional 21 shares during the period. Net Worth Advisory Group grew its position in UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after acquiring an additional 21 shares during the period. Bensler LLC grew its position in UnitedHealth Group by 0.3% in the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate's stock valued at $3,637,000 after acquiring an additional 22 shares during the period. Finally, Lakeridge Wealth Management LLC grew its position in UnitedHealth Group by 5.8% in the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate's stock valued at $220,000 after acquiring an additional 23 shares during the period. 87.86% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on UNH. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 6th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday, September 12th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.
View Our Latest Report on UnitedHealth Group
UnitedHealth Group Trading Up 0.7%
NYSE UNH opened at $347.82 on Thursday. The stock has a 50-day simple moving average of $304.76 and a 200 day simple moving average of $357.57. The company has a market capitalization of $315.01 billion, a PE ratio of 15.07, a P/E/G ratio of 2.25 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.